IL4 and myeloid sarcoma: Finally, in MS patients a deficiency in negative regulation of macrophage activation by Src homology region 2 domain-containing phosphatase-1 (SHP-1) was observed, leading to an enhanced response of these macrophages to both LPS and IL-4 [84,85].